Attenuated Expression of Apoptosis Stimulating Protein of p53-2 (ASPP2) in Human Acute Leukemia Is Associated with Therapy Failure

• Marcus M. Schittenhelm,

  Affiliation University Hospital Tübingen, Department of Hematology, Oncology, Rheumatology, Immunology and Pulmology, Tübingen, Germany

  ⨯
• Barbara Illing,

  Affiliation University Hospital Tübingen, Department of Hematology, Oncology, Rheumatology, Immunology and Pulmology, Tübingen, Germany

  ⨯
• Figen Ahmut,

  Affiliation University Hospital Tübingen, Department of Hematology, Oncology, Rheumatology, Immunology and Pulmology, Tübingen, Germany

  ⨯
• Katharina Henriette Rasp,

  Affiliation University Hospital Tübingen, Department of Hematology, Oncology, Rheumatology, Immunology and Pulmology, Tübingen, Germany

  ⨯
• Gunnar Blumenstock,

  Affiliation Department of Clinical Epidemiology and Applied Biometry, Eberhard Karls University Tübingen, Germany

  ⨯
• Konstanze Döhner,

  Affiliation University Hospital Ulm, Department of Internal Medicine III, Ulm, Germany

  ⨯
• Charles D. Lopez,

  Affiliation Department of Medicine, Division of Hematology and Medical Oncology, Oregon Health & Science University and The OHSU Knight Cancer Institute, Portland, Oregon, United States of America

  ⨯
• Kerstin M. Kampa-Schittenhelm

  * E-mail: kerstin.kampa-schittenhelm@med.uni-tuebingen.de

  Affiliation University Hospital Tübingen, Department of Hematology, Oncology, Rheumatology, Immunology and Pulmology, Tübingen, Germany

  ⨯